Comparison
NMN vs Mexidol (Emoxypine)
NMN
Nicotinamide mononucleotide — NAD+ precursor. Studied for cellular aging and metabolic health.
Mexidol (Emoxypine)
Russian prescription antioxidant and anti-anxiety compound. Membrane stabiliser used for cerebrovascular and anxiety conditions.
| Field | NMN | Mexidol (Emoxypine) |
|---|---|---|
| Category | neuroprotective | neuroprotective |
| Dose range | 250–1000mg | 125–500mg |
| Half-life | — | — |
| Onset | — | — |
| Evidence | EVIDENCEB | EVIDENCEC |
| Safety | ●●●●● | ●●●●○ |
| Legal (US) | USOTC | USResearch chemical |
| PubMed refs | 600 | 200 |
The comparison in plain English
Auto-generated from dataNMN and Mexidol (Emoxypine) are both in the neuroprotective category respectively. NMN Nicotinamide mononucleotide — NAD+ precursor. Mexidol (Emoxypine) Russian prescription antioxidant and anti-anxiety compound.
Bottom line
NMN (evidence B, safety 5/5) has a weaker evidence base than Mexidol (Emoxypine) (evidence C, safety 4/5). NMN has the slightly cleaner safety profile. For users new to either, the higher-evidence option is the safer first try.
Choose NMN if
NMN is the better fit when your goal aligns with its mechanism (Direct precursor to NAD+ — one biosynthetic step closer than nicotinamide riboside, bypassing the NRK1/NRK2 enzymatic step) and the dose range (250–1000mg) suits your protocol. Half-life is —h.
Choose Mexidol (Emoxypine) if
Mexidol (Emoxypine) is the better fit when your goal aligns with its mechanism (Antioxidant through scavenging reactive oxygen species and stabilising membrane lipid bilayer) and the dose range (125–500mg) suits your protocol. Half-life is —h.